NYSEMKT: NNVC
Nanoviricides Inc Stock Ownership - Who owns Nanoviricides?

Insider buying vs selling

Have Nanoviricides Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNVC insiders and whales buy or sell their stock.

NNVC Shareholders

What type of owners hold Nanoviricides Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Theracour Pharma Inc153.93%33,321,000$33.99MInsider
Milton Boniuk68.50%14,827,438$15.12MInsider
Anil Diwan9.45%2,044,918$2.09MInsider
Eugene Seymour5.77%1,248,814$1.27MInsider
Stephenson Fournier PLLC2.27%491,721$501.56kInsider
Meeta Vyas2.03%439,570$448.36kInsider
Vanguard Capital Management LLC0.00%919$937.38Institution
Vangrd0.00%919$937.38Institution
Geodec0.00%216$220.32Institution
Geode Capital Management LLC0.00%216$220.32Institution

1 of 3

NNVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNVC0.00%100.00%
COCP0.00%100.00%Net BuyingNet Buying
PDSB0.01%21.12%
LGVN0.02%99.98%Net SellingNet Selling
LTRN0.02%53.50%Net Buying

Nanoviricides Stock Ownership FAQ

Who owns Nanoviricides?

Nanoviricides (NYSEMKT: NNVC) is owned by 0.01% institutional shareholders, 241.94% Nanoviricides insiders, and 0.00% retail investors. Theracour Pharma Inc is the largest individual Nanoviricides shareholder, owning 33.32M shares representing 153.93% of the company. Theracour Pharma Inc's Nanoviricides shares are currently valued at $34.99M.

If you're new to stock investing, here's how to buy Nanoviricides stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.